Publications by authors named "Jesus Legido"

Claim this Profile
C
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Míriam Mañosa, Margalida Calafat, Elena Ricart, Pilar Nos, Eva Iglesias, Jesús Legido

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
Margalida Calafat, Carles Suria, Francisco Mesonero, Ruth de Francisco, Carmen Yagüe Caballero, Jesús Legido

Am J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, María José Casanova, Míriam Mañosa, Jesús Legido

Aliment Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
María Chaparro, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero, Jesús Legido

Aliment Pharmacol Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
Luis Fernández-Salazar, Fernando Muñoz, Jesús Barrio, Concepción Muñoz, Ramón Pajares, Jesús Legido

Scand J Gastroenterol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis.
Luis Fernández-Salazar, Jesús Barrio, Fernando Muñoz, Concepción Muñoz, Ramón Pajares, Jesús Legido

Rev Esp Enferm Dig· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
Konstantinos Karmiris, Peter Bossuyt, Dario Sorrentino, Tom Moreels, Antonella Scarcelli, Jesus Legido

J Crohns Colitis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bone metabolism changes in 100 patients with inflammatory bowel disease].
Jesús Legido, Javier P Gisbert, José Maté

Gastroenterol Hepatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Meningitis due to Listeria monocytogenes during adalimumab therapy].
Cecilia Gil, Jesús Legido, Carlos Cuenca, Ana Santamaría, María Victoria Sacristán

Gastroenterol Hepatol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk assessment and outpatient management in bleeding peptic ulcer.
Javier P Gisbert, Jesús Legido, Isabel Castel, María Trapero, José Cantero

J Clin Gastroenterol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease].
Javier P Gisbert, Marta Luna, Jesús Legido, Carlos Hermida, José Maté

Med Clin (Barc)· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis